Skip to Content
Skip to main content
CenGEM

CenGEM

A new cell and gene therapy approach for Friedreich's ataxia
Funder: Medical Research Council
Duration: May 2019 - April 2021
RNA composition of exosomes as potential biomarkers for cancer
Funder: Elva-1
Duration: May 2019 - April 2020
HBM4EU - European Human Biomonitoring Initiative
Funder: European Commission
Duration: March 2019 - December 2021
Data collection in support of the Endocrine Disruption (ED) assessment for non-target vertebrates
Funder: European Food Safety Authority
Duration: February 2019 - February 2020
Defining and exploiting the role of non-genetic variability in cancer biology
Funder: Wellcome Trust / University of Cambridge Institutional Strategic Support Fund
Duration: January 2019 - June 2020

Personal Fellowship

Milking the Thistle
Funder: IEHS
Duration: August 2018 - February 2019

Assessing the bioreactive fraction of the thislte in DNA damage repair and ageing

Low-cost Portable Molecular Diagnostic Platform for Rapid Detection of Poultry Infectious Pathogens (LMDP)
Funder: Biotechnology & Biological Sciences Research Council
Duration: April 2018 - March 2021
Technician/Scientific Officer Support
Funder: Mount Vernon Cancer Centre
Duration: April 2018 - March 2019
Elucidation of the metabolic signature of Friedreich’s ataxia
Funder: FARA-US
Duration: April 2018 - June 2021
Integrating mitochondrial metabolism and gene expression regulation in acute myeloid leukaemia
Funder: Isaac Newton Trust / Wellcome Trust ISSF / University of Cambridge Joint Research Grants Scheme
Duration: March 2018 - February 2019

Salary and research costs Research Associate (Dr Rashmi Kulkarni)

An investigation of the potential of SiNPs particles to enhance Adenovirus gene transfer
Funder: N4Pharma
Duration: January 2018 - October 2019

vector enhancement

Systematic Literature Review on Interactions in Chemical Mixtures
Funder: European Joint Research Centre
Duration: January 2018 - December 2018
Development of a study protocol for thyroid disruptor testing in the mammalian system
Funder: European Commission
Duration: January 2018 - June 2019
Development of a study protocol for thyroid disruptor testing in the mammalian system
Funder: European Commission Directorate-General for the Environment
Duration: December 2017 - February 2018
Modelling the t(7;12) infant leukaemia using Gene Editing Technology
Funder: Kidscan
Duration: October 2017 - October 2020
Modelling the t(7;12) Infant Leukaemia using Gene Editing Technology
Funder: Kidscan
Duration: October 2017 - September 2020
Towards an improved human risk assessment of pesticides on male reproductive health
Funder: Danish Environment Ministry
Duration: October 2017 - September 2020
PhD studentship: use of liquid biopsies as diagnostic and prognostic biomarkers for lung cancer
Funder: Mount Vernon Cancer Centre
Duration: October 2017 - September 2020
PhD studentship - GSK Charlotte Kay
Funder: GlaxoSmithKline
Duration: October 2017 - September 2023
The Role of Genetic, Epigenetic and Transcriptional Heterogeneities in Pre-leukaemia to Leukaemia Progression in AML
Funder: Lady Tata Memorial Trust
Duration: October 2017 - September 2020

PhD Studentship to Shikha Gupta (University of Cambridge)

Aged Veterans - Centre of Excellence
Funder: Nuclear Community Charity Fund
Duration: September 2017 - August 2020
Genomic assessment of nuclear test veterans and their families
Funder: Nuclear Community Charity Fund
Duration: September 2017 - August 2020
Radiation risks from high-LET alpha-emitters using radium-223 as a model.
Funder: Public Health England
Duration: August 2017 - July 2020
Microbiology Society Harry Smith Vacation Studentship 2017
Funder: Microbiology Society
Duration: July 2017 - August 2017

Brunel University London
Kingston Lane
Uxbridge
Middlesex UB8 3PH

Tel: +44 (0)1895 274000

Fax: +44 (0)1895 232806

Security: +44 (0)1895 255786

Directions to the campus

Brunel.ac.uk uses cookies to make our site better for you. By clicking on or navigating this site, you accept our use of cookies in accordance with our cookie policy.

Close this message